Rhenman & Partners Asset Management AB - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$534,067
-79.3%
314,157
-61.7%
0.06%
-78.1%
Q4 2022$2,574,800
-28.5%
820,0000.0%0.27%
-28.6%
Q3 2022$3,600,000
+24.2%
820,000
+17.1%
0.38%
+14.6%
Q2 2022$2,898,000
-34.5%
700,000
-8.1%
0.33%
-24.5%
Q1 2022$4,424,000
-26.0%
761,429
-0.5%
0.44%
+9.8%
Q4 2021$5,975,000
-13.3%
765,0000.0%0.40%
-18.0%
Q3 2021$6,893,000
-24.7%
765,0000.0%0.48%
-22.2%
Q2 2021$9,157,000
-4.5%
765,0000.0%0.62%
-6.9%
Q1 2021$9,585,000
-25.3%
765,000
-6.9%
0.67%
-36.1%
Q4 2020$12,826,000
+101.1%
821,888
+21.8%
1.05%
+84.5%
Q3 2020$6,379,000
+5.5%
675,0000.0%0.57%
-13.2%
Q2 2020$6,048,000
+35.6%
675,000
-3.6%
0.65%
+4.5%
Q1 2020$4,459,000
-23.9%
700,0000.0%0.62%
-2.6%
Q4 2019$5,859,000
-11.9%
700,000
-4.7%
0.64%
-23.0%
Q3 2019$6,650,000
-22.2%
734,811
-7.4%
0.83%
-11.5%
Q2 2019$8,551,000
+6.2%
793,957
-5.9%
0.94%0.0%
Q1 2019$8,051,000
-36.5%
843,957
-23.6%
0.94%
-35.0%
Q4 2018$12,673,000
-37.6%
1,103,957
-7.8%
1.45%
-28.8%
Q3 2018$20,295,000
+35.9%
1,197,357
+13.8%
2.03%
+33.0%
Q2 2018$14,937,000
+207.3%
1,051,933
+311.2%
1.53%
+155.3%
Q1 2018$4,860,000
+15.9%
255,7930.0%0.60%
+5.6%
Q4 2017$4,195,000255,7930.57%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders